Cell Point IPO GMP, Review, Price, Allotment
Introduction
The Cell Point India IPO is an upcoming event in the stock market that has garnered significant attention. This article will provide a detailed overview of the Cell Point IPO, including its description, IPO details, financial performance, valuations, margins, and IPO dates. We will also discuss the company’s retail operations, payment options, and its presence in the market. So, let’s delve into the specifics of the Cell Point IPO.
Cell Point IPO Description
Cell Point India, established in 2013, is a multi-brand retail company specializing in the sale of smartphones, tablets, mobile accessories, and related products. The company operates 75 retail stores across Andhra Pradesh, offering a wide range of brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Redmi, Techno, One Plus, and GIONEE. In addition to mobile devices, Cell Point India also sells smart televisions from brands like Xiaomi, Realme, and One Plus. The company’s commitment to providing a diverse range of products under one roof has contributed to its popularity among customers.
To facilitate the purchase of its products, Cell Point India offers various payment options, including credit/EMI facilities, UPI, vouchers, and pay on delivery. The company has collaborated with prominent credit houses like Bajaj Finserv, Capital First, and TVS Credit finance to provide flexible payment solutions to its customers.
Cell Point IPO Details
The following are the key details regarding the Cell Point IPO:
| Cell Point IPO Dates | 22 – 27 Jun 2023 |
| Cell Point IPO Price | INR 100 per share |
| Fresh issue | 50,34,000 shares (INR 50.34 crore) |
| Offer For Sale | NIL |
| Total IPO size | 50,34,000 shares (INR 50.34 crore) |
| Minimum bid (lot size) | 1,200 shares (INR 120,000) |
| Face Value | INR 10 per share |
| Retail Allocation | 50% |
| Listing On | NSE SME |
- IPO Dates: The IPO will open for subscription from June 22, 2023, to June 27, 2023.
- IPO Price: Each share of the Cell Point IPO is priced at INR 100.
- Fresh Issue: The IPO comprises 50,34,000 shares, amounting to INR 50.34 crore.
- Offer For Sale: There is no offer for sale in this IPO.
- Total IPO Size: The total IPO size is 50,34,000 shares, equivalent to INR 50.34 crore.
- Minimum Bid (Lot Size): Investors can bid for a minimum lot size of 1,200 shares, totaling INR 120,000.
- Face Value: The face value of each share is INR 10.
- Retail Allocation: Retail investors are allocated 50% of the IPO shares.
- Listing On: The IPO will be listed on the NSE SME.
Cell Point Financial Performance
Let’s examine the financial performance of Cell Point India over the past few years:
| Financial Year | Revenue (INR crores) | Expenses (INR crores) | Net Income (INR crores) |
|---|---|---|---|
| FY 2020 | 277.56 | 275.73 | 1.60 |
| FY 2021 | 223.01 | 222.29 | 0.69 |
| FY 2022 | 269.16 | 267.62 | 1.65 |
| 9M FY 2023 | 220.74 | 213.57 | 5.81 |
Figures in INR crores unless specified otherwise
The financial data reveals that Cell Point India has shown consistent revenue growth over the years. Despite facing some challenges, the company has managed to maintain a positive net income.
Cell Point Valuations & Margins
Let’s analyze the valuations and margins of Cell Point India:
| Financial Year | EPS | PE Ratio | RONW (%) | NAV | ROCE (%) | EBITDA (%) | Debt/Equity |
|---|---|---|---|---|---|---|---|
| FY 2020 | 14.06 | – | 14.51 | 96.90 | 20.72 | 3.35 | 3.51 |
| FY 2021 | 6.07 | – | 5.90 | 102.97 | 13.75 | 3.39 | 3.85 |
| FY 2022 | 14.47 | 6.91 | 12.32 | 117.45 | 16.06 | 3.96 | 4.24 |
*Compiled by IPO Central from Prospectus
The earnings per share (EPS) for Cell Point India have shown an upward trend, indicating positive growth. The company’s return on net worth (RONW) and return on capital employed (ROCE) have also improved, signifying increased efficiency and profitability.
Cell Point IPO Dates & Listing Performance
The timeline for the Cell Point IPO and its listing performance is as follows:
- IPO Opening Date: June 22, 2023
- IPO Closing Date: June 27, 2023
- Finalization of Basis of Allotment: July 3, 2023
- Initiation of Refunds: July 4, 2023
- Transfer of Shares to Demat Accounts: July 5, 2023
- IPO Listing Date: July 6, 2023
- Opening Price on NSE SME: Coming soon
- Closing Price on NSE SME: Coming soon
Conclusion
The Cell Point India IPO presents an opportunity for investors to participate in the growth story of a well-established multi-brand retail company. With a diverse product range and a strong retail presence in Andhra Pradesh, Cell Point India has been able to capture a significant market share. The company’s financial performance showcases its potential for further growth and profitability. Investors should carefully evaluate the IPO details and consider seeking professional advice before making investment decisions.
FAQs
How often does the IPO Grey Market Premium change?
The Grey Market Premium is dynamic and can change frequently, influenced by market conditions and investor sentiment. It is advisable to stay updated with the latest figures through reliable sources.
Can investors participate in the Grey Market trading?
Grey Market trading is conducted through a network of dealers, and participation is limited to select individuals or entities. It is an unofficial market and not regulated like the stock exchange.
Should investors rely solely on the IPO Grey Market Premium for investment decisions?
No, investors should consider the Grey Market Premium as one of several factors when making investment decisions. Thorough research, analysis of company fundamentals, and expert advice are equally important.
What is the significance of Kostak rates in IPO investments?
Kostak rates represent the price at which investors can sell their IPO application before listing. It provides an opportunity for early exits. Investors should evaluate both GMP and Kostak rates to make informed decisions.
Disclaimer:
The information provided in this article is for informational purposes only and should not be construed as investment advice. Investors are advised to conduct their own research and consult with financial professionals before making any investment decisions.
